TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7485665

Group type: EXPERIMENTAL
Intervention: Nursing intervention
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Knowledge about birth control
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Communication with partner
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: No induced abortion
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Not using condoms due to starting oral contraceptive pill regimens
Number of subjects: 360
Study: 1560323

Group type: EXPERIMENTAL
Intervention: CORN/SOY formula
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: COCO/SOY formula
Number of subjects: 45

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Formulas (CORN/SOY and COCO/SOY)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Human milk
Number of subjects: 45
Study: 4053698

Group type: EXPERIMENTAL
Intervention: Erythromycin 500 mg twice daily for seven days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Erythromycin 500 mg twice daily for four days
Number of subjects: 73
Study: 31892665

Group type: EXPERIMENTAL
Intervention: Percutaneous transforaminal endoscopic discectomy (PTED)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Paraspinal minitubular microdiscectomy (PMTM)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: PTED
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: PMTM
Number of subjects: 280
Study: 29343256

Group type: EXPERIMENTAL
Intervention: 3 g/d green cardamom for 10 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo for 10 weeks
Number of subjects: 80
Study: 27115400

Group type: EXPERIMENTAL
Intervention: HIV-PASS (HIV-Pain and Sadness Study)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Health education control arm
Number of subjects: 23
Study: 26571885

Group type: EXPERIMENTAL
Intervention: Floating-needle therapy combined with rehabilitation training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Rehabilitation training (control group)
Number of subjects: 80
Study: 24012926

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subgenual cingulate gyrus (SCG) with high intensity 130 Hz stimulation for 24 hours
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Chronic stimulation of the SCG
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sham stimulation (control condition)
Number of subjects: 6
Study: 21466944

Group type: EXPERIMENTAL
Intervention: Outcome Monitoring (OM) + Recovery Management Checkups (RMC)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Outcome Monitoring (OM) only
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Identifying a person in relapse
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Linking and retaining a person in treatment
Number of subjects: 446
Study: 18303458

Group type: EXPERIMENTAL
Intervention: Microdiscectomy (D)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Microscopic sequestrectomy (S)
Number of subjects: 84
Study: 17108480

Group type: EXPERIMENTAL
Intervention: SEAS.02 exercises
Number of subjects: 48

Group type: COMPARATOR
Intervention: CONT exercises
Number of subjects: 48
Study: 12717124

Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl induction regimen with atracurium
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol-fentanyl induction regimen without atracurium
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Excellent intubating conditions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Good intubating conditions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Poor intubating conditions
Number of subjects: 80
Study: 10945384

Group type: EXPERIMENTAL
Intervention: Intermittent antegrade warm blood cardioplegia with normothermic bypass (group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combined antegrade and retrograde cold crystalloid cardioplegia with hypothermic bypass (group 2)
Number of subjects: 30
Study: 9447502

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 7713274

Group type: EXPERIMENTAL
Intervention: Type 1 DM children
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy children (control)
Number of subjects: 36
Study: 3128309

Group type: EXPERIMENTAL
Intervention: Oral Ftorafur (1 g/m2/day for 21 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous 5-fluorouracil (5-FU) (500 mg/m2/day for 5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 0
Study: 28695324

Group type: EXPERIMENTAL
Intervention: Almonds (56 g daily)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cookies (isocaloric control)
Number of subjects: 84
Study: 27206386

Group type: EXPERIMENTAL
Intervention: 0.5mg pWRG/VEE via IM-EP (N=8)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 2.0mg pWRG/VEE via IM-EP (N=9)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.08mg pWRG/VEE via ID-EP (N=8)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.3mg pWRG/VEE via ID-EP (N=8)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Saline placebo via IM-EP (N=4)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Saline placebo via ID-EP (N=4)
Number of subjects: 37
Study: 25514559

Group type: EXPERIMENTAL
Intervention: 500 mg catechins
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 500 mg theaflavins
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 300 mg theaflavins
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lower doses of theaflavins
Number of subjects: 24
Study: 22179720

Group type: EXPERIMENTAL
Intervention: Working memory and inhibitory control with attention monitoring
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Working memory and inhibitory control without attention monitoring
Number of subjects: 128

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Working memory and inhibitory control (both conditions)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Passive attention monitoring via EEG
Number of subjects: 128
Study: 19423101

Group type: EXPERIMENTAL
Intervention: In vitro maturation (IVM) of oocytes
Number of subjects: 173

Group type: COMPARATOR
Intervention: Oocytes matured in vivo
Number of subjects: 173

Group type: COMPARATOR
Intervention: Germinal vesicle (GV) oocytes
Number of subjects: 173

Group type: COMPARATOR
Intervention: Meiosis I oocytes
Number of subjects: 173
Study: 19062506

Group type: EXPERIMENTAL
Intervention: PAPP-A
Number of subjects: 400
Study: 15707381

Group type: EXPERIMENTAL
Intervention: Plyometric training (n = 13)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 28
Study: 11918358

Group type: EXPERIMENTAL
Intervention: Interactive tutorial
Number of subjects: 58

Group type: COMPARATOR
Intervention: Computer-assisted instruction (CAI)
Number of subjects: 58
Study: 7851000

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: H2 receptor antagonists
Number of subjects: 0
Study: 2472515

Group type: COMPARATOR
Intervention: Synthetic atrial natriuretic peptide (ANP) 1.0, 1.5, and 2.0 micrograms/kg in CRF; 1.0, 1.5, and 3.0 micrograms/kg in NS.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31977817

Group type: EXPERIMENTAL
Intervention: Romosozumab (70 mg, 140 mg, 210 mg)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 30802304

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) with oral colistin, tobramycin, and amphotericin B
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Control group receiving intravenous cefazolin and metronidazole for perioperative prophylaxis
Number of subjects: 455

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 455
Study: 28881549

Group type: EXPERIMENTAL
Intervention: Cholera vaccine infused with antacids
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 25447575

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange and rituximab (Group A)
Number of subjects: 500

Group type: COMPARATOR
Intervention: No treatment (Group B)
Number of subjects: 500
Study: 23867152

Group type: EXPERIMENTAL
Intervention: Romanian deadlift (DL) training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Isolated lumbar extension (LUMX) training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 20691481

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg/day
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg/day (for inadequate responders)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 310
Study: 19420280

Group type: EXPERIMENTAL
Intervention: Internet intervention (n = 12)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care (n = 10)
Number of subjects: 22
Study: 16461314

Group type: EXPERIMENTAL
Intervention: Dexamethasone plus diclofenac eye drops (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexamethasone (group A)
Number of subjects: 60
Study: 15492131

Group type: EXPERIMENTAL
Intervention: hs-CRP > or = 3.0 mg/L
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 379

Group type: COMPARATOR
Intervention: Smoking cessation
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Increase in waist girth during follow-up
Number of subjects: 379

Group type: COMPARATOR
Intervention: Decrease in smoking
Number of subjects: 379
Study: 11566622

Group type: EXPERIMENTAL
Intervention: Local administration of IL-1beta (10 ng/ml, once a day for 7 days)
Number of subjects: 0
Study: 9783757

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 9323

Group type: COMPARATOR
Intervention: Diclofenac 100 mg slow release
Number of subjects: 9323
Study: 8181260

Group type: EXPERIMENTAL
Intervention: 200 mg oral pirenzepine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2815382

Group type: EXPERIMENTAL
Intervention: Dressings until sutures were removed
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dressings during the first 24 hours after operation only
Number of subjects: 0
Study: 942021

Group type: EXPERIMENTAL
Intervention: Peripheral nerve stimulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-stimulator technique (reliance on paraesthesiae)
Number of subjects: 60
Study: 29995697

Group type: EXPERIMENTAL
Intervention: AVT with amlodipine and/or renin angiotensin blockade
Number of subjects: 83

Group type: COMPARATOR
Intervention: AnonVT with the nonvasodilating beta‐blocker metoprolol
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: AVT and AnonVT
Number of subjects: 83
Study: 28157412

Group type: EXPERIMENTAL
Intervention: tPAD device
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oral jet nebulizer
Number of subjects: 6
Study: 26053958

Group type: EXPERIMENTAL
Intervention: Multi-component intervention (50-minute motivational interview by a nurse and online self-help material)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control group (brief advice session)
Number of subjects: 255
Study: 23696687

Group type: EXPERIMENTAL
Intervention: Hospital-at-home care
Number of subjects: 53

Group type: COMPARATOR
Intervention: In-patient hospital care
Number of subjects: 53
Study: 22448907

Group type: EXPERIMENTAL
Intervention: Orthotic management (static or dynamic knee-ankle-foot-orthoses) for 1 year
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care (physical therapy, manual stretching)
Number of subjects: 66
Study: 19507268

Group type: EXPERIMENTAL
Intervention: Tianwang Buxin Pills (TBPs)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 17554202

Group type: EXPERIMENTAL
Intervention: Tomato lycopene extract supplementation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 56
Study: 15139870

Group type: EXPERIMENTAL
Intervention: Methadone maintenance (n = 91) with monthly 1 hour/week of psychosocial therapy during the first 6 months
Number of subjects: 179

Group type: COMPARATOR
Intervention: 180-day detoxification (n = 88) with 3 hours/week of psychosocial therapy and 14 education sessions during the first 6 months
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Methadone maintenance
Number of subjects: 179
Study: 12225508

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ivermectin (IVM)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 9648550

Group type: EXPERIMENTAL
Intervention: Bromocriptine (low-dose D2 dopamine receptor agonist)
Number of subjects: 24
Study: 7988261

Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2 on days 1 and 29) and fluorouracil (1 g/m2 for 24 h as continuous infusion on days 1 to 4 and 29 to 32) with thoracic radiation (30 Gy in 15 fractions on days 1 to 19)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 85
Study: 2567439

Group type: EXPERIMENTAL
Intervention: Acupuncture at points specific for the treatment of substance abuse
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupuncture at nonspecific points (control group)
Number of subjects: 80
Study: 4396186

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 12
Study: 31762434

Group type: EXPERIMENTAL
Intervention: Montessori-based activities
Number of subjects: 40

Group type: COMPARATOR
Intervention: Reading a newspaper (control condition)
Number of subjects: 40
Study: 30921645

Group type: EXPERIMENTAL
Intervention: Irinotecan hydrochloride liposome injection (IHLI)
Number of subjects: 0
Study: 28679449

Group type: EXPERIMENTAL
Intervention: Abatacept 3 mg/kg on day 1, 15, and 29, followed by 10 mg/kg every 28 days for 5 months
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Abatacept 10 mg/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 15
Study: 26596672

Group type: EXPERIMENTAL
Intervention: Afatinib alone 40 mg orally once per day
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Afatinib plus vinorelbine 40 mg per day plus intravenous vinorelbine 25 mg/m2 once per week
Number of subjects: 121

Group type: COMPARATOR
Intervention: Investigator's choice
Number of subjects: 121
Study: 23808999

Group type: EXPERIMENTAL
Intervention: Berberine hydrochloride (500 mg) three times daily before meals for 3 months
Number of subjects: 24
Study: 22189642

Group type: EXPERIMENTAL
Intervention: Minute Maid Original® (MM)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Synthetic Juice (SJ)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1% Citric Acid (CA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Florida Natural Original® (FN)
Number of subjects: 80
Study: 19501755

Group type: EXPERIMENTAL
Intervention: Eating with a friend
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Sharing from a common serving bowl
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Eating from small plates
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Taking second helpings
Number of subjects: 57
Study: 17132050

Group type: EXPERIMENTAL
Intervention: fMRI brain responses to novel sequences of objects during an incidental target detection task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fMRI brain responses to novel sequences of objects
Number of subjects: 0
Study: 12860548

Group type: EXPERIMENTAL
Intervention: Relaxin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (Men)
Number of subjects: 5
Study: 10854946

Group type: EXPERIMENTAL
Intervention: BEMP (vindesine, cisplatin, bleomycin, mitomycin-C)
Number of subjects: 4424
Study: 9104380

Group type: EXPERIMENTAL
Intervention: Patient information video during the informed consent process
Number of subjects: 90

Group type: COMPARATOR
Intervention: Written information only
Number of subjects: 90
Study: 8256085

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3510617

Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Prochlorperazine maleate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29180454

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (8 weeks treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine (active control)
Number of subjects: 0
Study: 27744584

Group type: EXPERIMENTAL
Intervention: High intensity (INT) training (3-5 RM, 3-min rest interval)
Number of subjects: 29

Group type: COMPARATOR
Intervention: High volume (VOL) training (10-12 RM, 1-min rest interval)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High intensity (INT) training
Number of subjects: 29

Group type: COMPARATOR
Intervention: High volume (VOL) training
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both INT and VOL training
Number of subjects: 29
Study: 24888475

Group type: EXPERIMENTAL
Intervention: Resuscitation scenario with additional distractors (noise, scripted family member)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control scenario without additional distractors
Number of subjects: 30
Study: 22437999

Group type: EXPERIMENTAL
Intervention: Intrepid Dynamic Exoskeletal Orthosis (IDEO)
Number of subjects: 18

Group type: COMPARATOR
Intervention: BlueRocker
Number of subjects: 18

Group type: COMPARATOR
Intervention: Posterior leaf spring orthosis
Number of subjects: 18

Group type: COMPARATOR
Intervention: No brace
Number of subjects: 18
Study: 19712933

Group type: EXPERIMENTAL
Intervention: TMD+VOO
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: TMD+nuts
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 49
Study: 17938573

Group type: EXPERIMENTAL
Intervention: CVD 1208S (10(9) CFU)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: CVD 1208S (10(8) CFU)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 15723448

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg every 12 hours for a total of 5 doses)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg every 12 hours for a total of 5 doses)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 12422093

Group type: EXPERIMENTAL
Intervention: Surgical thrombectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovascular procedures
Number of subjects: 0
Study: 9613786

Group type: EXPERIMENTAL
Intervention: Traditional inpatient setting
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Partial outpatient setting
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Total outpatient setting
Number of subjects: 94

Group type: COMPARATOR
Intervention: All settings combined
Number of subjects: 94
Study: 7625622

Group type: COMPARATOR
Intervention: Placebo four times daily
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: 200 micrograms of misoprostol twice daily
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: 200 micrograms of misoprostol three times daily
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: 200 micrograms of misoprostol four times daily
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Misoprostol twice daily vs. Misoprostol three times daily
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Misoprostol four times daily
Number of subjects: 1197

Group type: EXPERIMENTAL
Intervention: Misoprostol twice daily and three times daily
Number of subjects: 1197
Study: 2196620

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 343500

Group type: EXPERIMENTAL
Intervention: 5 mg nitrazepam
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 10 mg nitrazepam
Number of subjects: 34
Study: 31812487

Group type: EXPERIMENTAL
Intervention: Azithromycin (n = 32)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (n = 37)
Number of subjects: 69
Study: 31196447

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 165502

Group type: COMPARATOR
Intervention: Control
Number of subjects: 165502
Study: 26342731

Group type: EXPERIMENTAL
Intervention: Early combined immunosuppression (ECI)
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 1084
Study: 23656257

Group type: EXPERIMENTAL
Intervention: Social support amount among caregivers
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Coping methods among caregivers
Number of subjects: 188

Group type: COMPARATOR
Intervention: Social support satisfaction
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Social support by health status
Number of subjects: 188
Study: 21098507

Group type: EXPERIMENTAL
Intervention: Phenylbutyrate therapy
Number of subjects: 0
Study: 19212615

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial infusion (TAI) of 120 mg/body cisplatin twice a month at an interval of 4 weeks
Number of subjects: 26
Study: 15999305

Group type: EXPERIMENTAL
Intervention: Pelvitrainer (PT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rabbit model (RM)
Number of subjects: 12
Study: 12439700

Group type: EXPERIMENTAL
Intervention: Amifostine (740 mg/m²) before HDM (200 mg/m²)
Number of subjects: 41
Study: 10734533

Group type: EXPERIMENTAL
Intervention: Health education and self breast examination
Number of subjects: 3003

Group type: COMPARATOR
Intervention: Baseline study
Number of subjects: 3003
Study: 1776746

Group type: EXPERIMENTAL
Intervention: Essential fatty acids (EFAs) plus appropriate antioxidants
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7347596

Group type: EXPERIMENTAL
Intervention: Cimetidine of sustained release
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional cimetidine
Number of subjects: 20